These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 24614146)
1. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions. Aronow ME; Chew EY Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146 [TBL] [Abstract][Full Text] [Related]
2. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421 [TBL] [Abstract][Full Text] [Related]
3. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. Age-Related Eye Disease Study 2 Research Group JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932 [TBL] [Abstract][Full Text] [Related]
4. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18. van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY; Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387 [TBL] [Abstract][Full Text] [Related]
14. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657 [TBL] [Abstract][Full Text] [Related]
15. A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration. García-Layana A; Recalde S; Hernandez M; Abraldes MJ; Nascimento J; Hernández-Galilea E; Olmedilla-Alonso B; Escobar-Barranco JJ; Zapata MA; Silva R; Caballero Arredondo M; Lopez-Sabater MC; Mendez-Martínez S; Pardiñas-Barón N; Calvo P; Fernández-Robredo P Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920232 [TBL] [Abstract][Full Text] [Related]
17. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD. Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596 [TBL] [Abstract][Full Text] [Related]
18. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial. Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529 [TBL] [Abstract][Full Text] [Related]
19. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. ; Papudesu C; Clemons TE; Agrón E; Chew EY Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456 [TBL] [Abstract][Full Text] [Related]
20. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]